Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Understand the scenarios where a cash back credit card is the best choice. Make your spending count with this guide.
26,647 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Markets edged lower in March as crypto regulation chatter intensified. Circle CRCL led the headlines with a sharp mov...
CME is moving to introduce Bitcoin volatility futures that track market expectations of price swings, separate from B...
QUBT surged alongside quantum peers on policy chatter, but the rally raises questions about fundamentals and governme...
When a fund trims large holdings, it can signal shifting risk and opportunity. This article explains why an investmen...
LyondellBasell shares have surged about 74% year-to-date, trading near $75 as of mid-March 2026. The rally comes desp...
Volatile markets test an investor’s nerves and resolve. The key to thriving, not just surviving, is focusing on a dis...
Mind Robotics has rapidly transformed Rivian's focus, reaching a multi-billion dollar valuation. Learn the two key wa...
The S&P 500 is up this year, but history offers guidance on what comes next. Learn the patterns, risks, and practical...
This article analyzes Summit's Q4 2025 earnings context, what the numbers could imply for the summit (smmt) 2025 earn...
B&G Foods' Q1 2026 earnings set the stage for a cautious yet encouraging year. This guide breaks down the drivers, ri...
If SpaceX ever files for an IPO, the prospectus would reveal the core drivers, the risks, and the questions investors...